Survival of cancer patients in Finland 1955-1994

Acta Oncologica

Volumn 38, Issue SUPPL.12, 1999, Pages 1-103

  Dickman, Paul W ^a,b   Hakulinen, Timo ^a   Luostarinen, Tapio ^a   Pukkala, Eero ^a   Sankila, Risto ^a   Söderman, Bengt ^a   Teppo, Lyly ^a  

^a FINNISH CANCER REGISTRY   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER; CANCER CONTROL; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CYTODIAGNOSIS; EARLY DIAGNOSIS; FEMALE; FINLAND; FOLLOW UP; HEALTH CARE MANAGEMENT; HEALTH EDUCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS; UTERINE CERVIX CANCER; ADOLESCENT; CHILD; INFANT; MIDDLE AGED; MORTALITY; NEOPLASM; NEWBORN; PRESCHOOL CHILD; REGISTER; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FINLAND; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 0032602929     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/028418699432996     Document Type: Article

References (43)

1. Finnish Cancer Registry. Cancer Incidence in Finland 1995. Cancer Society of Finland Publication No. 58. Helsinki: Cancer Society of Finland, 1997.
2. Hakulinen T, Pukkala E, Hakama M, Lehtonen M, Saxén E, Teppo L. Survival of cancer patients in Finland in 1953-1974. Ann Clin Res 1981; 13 (Suppl 31): 1-101.
3. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994; 33: 365-9.
4. Hakulinen T. Health care system, cancer registration and follow-up of cancer patients in Finland. In: Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J, eds. Survival of cancer patients in Europe: the EUROCARE study. IARC Scientific Publications No. 132. Lyon: International Agency for Research on Cancer, 1995: 53-4.
5. Pukkala E. Use of record linkage in small-area studies. In: Elliott P, Cuzick J, English D, Stern R, eds. Geographical and environmental epidemiology: methods for small-area studies. Oxford: Oxford University Press, 1992: 125-31.
6. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. J Natl Cancer Inst Monogr 1961; 6: 101-21.
7. Berkson J, Gage RP. Calculation of survival rates for cancer. Mayo Clin Proc 1950; 25: 270-86.
8. Hakulinen T, Abeywickrama K. A computer program package for relative survival analysis. Comput Programs Biomed 1985; 19: 197-207.
9. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 933-42.
10. Hakulinen T, Rahiala M. An example of the risk dependence and additivity of intensities in the theory of competing risks. Biometrics 1977; 33: 557-9.
11. Cutler SJ, Axtell LM. Partitioning of a patient population with respect to different mortality patterns. J Am Stat Assoc 1963; 58: 701-12.
12. Greenwood M. The errors of sampling of the survivorship table. Reports on public health and medical subjects, Vol. 33. London: Her Majesty's Stationery Office, 1926.
13. Zahl PH, Tretli S. Long-term survival of breast cancer in Norway by age and clinical stage. Stat Med 1997; 16: 1435-49.
14. Hakama M, Joutsenlahti U, Virtanen A, Räsänen-Virtanen U. Mass screening for cervical cancer in Finland 1963-71. Ann Clin Res 1975; 7: 101-11.
15. Läärä E, Day N, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987; 1: 1247-9.
16. Hakama M, Hristova L. Effect of screening in the Nordic cancer control up to the year 2017. Acta Oncol 1997; 36: 119-28.
17. Hristova L, Hakama M. Effect of screening for cancer in the Nordic countries on deaths, costs and quality of life up to the year 2017. Acta Oncol 1997; 36 (Suppl 9): 1-60.
18. Auvinen A, Karjalainen S, Pukkala E. Social class and cancer patient survival in Finland. Am J Epidemiol 1995; 142: 1089-102.
19. Central Statistical Office of Finland. Population census 1970. Vol. 9: Occupation and social position. Helsinki: Central Statistical Office of Finland, 1974.
20. Rauhala U. The Social Stratification of Finnish Society. Porvoo: Society for Social Policy, 1966. In Finnish.
21. Central Statistical Office of Finland. Classification of socioeconomic status. Handbook no. 17. Helsinki: Central Statistical Office of Finland, 1989. In Finnish.
22. Hakulinen T, Tenkanen L. Regression analysis of relative survival rates. Appl Stat 1987; 36: 309-17.
23. Leon D, Wilkinson RG. Inequalities in prognosis: socio-economic differences in cancer and heart disease survival. In: Fox J, ed. Health inequalities in European countries. Aldershot: Gower, 1989: 280-300.
24. Karjalainen S. Equity and cancer patient survival [thesis]. Tampere, Finland: University of Tampere, 1991. Acta Universitatis Tamperensis, series A: 316.
25. Schrijvers C. Socioeconomic inequalities in cancer survival in the Netherlands and Great Britain: small-area based studies using Cancer Registry data [thesis]. Rotterdam: Erasmus University, The Netherlands, 1996.
26. Karjalainen S. Geographical variation in cancer patient survival in Finland: chance, confounding, or effect of treatment. J Epidemiol Community Health 1990; 44: 210-4.
27. Karjalainen S, Pukkala E. Social class as a prognostic factor in breast cancer survival. Cancer 1990; 66: 819-26.
28. Schrijvers CT, Mackenbach JP. Cancer patient survival by socioeconomic status in seven countries: a review for six common cancer sites. J Epidemiol Community Health 1994; 48: 441-6.
29. Schrijvers CT, Mackenbach JP, Lutz JM, Quinn MJ, Coleman MP. Deprivation, stage at diagnosis and cancer survival. Int J Cancer 1995; 63: 324-9.
30. Schrijvers CT, Mackenbach JP, Lutz JM, Quinn MJ, Coleman MP. Deprivation and survival from breast cancer. Br J Cancer 1995; 72: 738-43.
31. Schrijvers CT, Coebergh JW, van der Heijden LH, Mackenbach JP. Socioeconomic status and breast cancer survival in the southeastern Netherlands, 1980-1989. Eur J Cancer 1995; 31A: 1660-4.
32. Schrijvers CT, Coebergh JW, van der Heijden LH, Mackenbach JP. Socioeconomic variation in cancer survival in the southeastern Netherlands, 1980-1989. Cancer 1995; 75: 2946-53.
33. Dickman PW, Auvinen A, Voutilainen ET, Hakulinen T. Measuring social class differences in cancer patient survival: is it necessary to control for social class differences in general population mortality? A Finnish population-based study. J Epidemiol Community Health 1998; 52: 727-34.
34. Dickman PW, Gibberd RW, Hakulinen T. Estimating potential savings in cancer deaths by eliminating regional and social class variation in cancer survival in the Nordic countries. J Epidemiol Community Health 1997; 51: 289-98.
35. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J, eds. Survival of cancer patients in Europe: the EUROCARE study. IARC Scientific Publications No. 132. Lyon: International Agency for Research on Cancer, 1995.
36. Engeland A, Haldorsen T, Tretli S, et al. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic cancer registries. APMIS 1995; 103 (Suppl 49): 1-163.
37. Engeland A, Haldorsen T, Dickman PW, et al. Relative survival of cancer patients. A comparison between Denmark and the other Nordic countries. Acta Oncol 1998; 37: 49-59.
38. Tretli S, Engeland A, Haldorsen T, et al. Prostate cancer - look to Denmark? J Natl Cancer Inst 1996; 88: 128.
39. Parkin DM, Hakulinen T. Analysis of survival. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, eds. Cancer registration: principles and methods. IARC Scientific Publications No. 95. Lyon: International Agency for Research on Cancer, 1991: 159-76.
40. Hakulinen T. On long-term relative survival rates. J Chron Dis 1977; 30: 431-43.
41. Sankila R, Pukkala E, Teppo L. Risk of subsequent malignant neoplasms among 470000 cancer patients in Finland, 1953-1991. Int J Cancer 1995; 60: 464-70.
42. Berrino F, Micheli A, Sant M, Capocaccia R. Interpreting survival differences and trends. Tumori 1997; 83: 9-16.
43. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312: 1604-8.